Skip to Content

Dermaxon Logo Dermaxon

Further exploring the brain-skin connection for a better life

April 2017

DermaXon presented at the 2017 Society for Investigative Dermatology Annual Meeting, May 2017, Portland, USA. Results presented confirmed the efficacy of our CYP26 inhibitors in organotypic model of Darier’s disease.

< Back to News
^ Back to Top ^ Back to Top
MENU